Cargando…

Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke

Stroke remains the number one cause of disability in the adult population. Despite scientific progress in our understanding of stroke pathology, only one treatment (tissue plasminogen activator or tPA) is able to afford benefits but to less than 3% of ischemic stroke patients. The development of exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Yuji, Cortes, Lourdes, Sanberg, Cyndy, Acosta, Sandra, Bickford, Paula C., Borlongan, Cesar V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397535/
https://www.ncbi.nlm.nih.gov/pubmed/22837703
http://dx.doi.org/10.3390/ijms13067424
_version_ 1782238200650006528
author Kaneko, Yuji
Cortes, Lourdes
Sanberg, Cyndy
Acosta, Sandra
Bickford, Paula C.
Borlongan, Cesar V.
author_facet Kaneko, Yuji
Cortes, Lourdes
Sanberg, Cyndy
Acosta, Sandra
Bickford, Paula C.
Borlongan, Cesar V.
author_sort Kaneko, Yuji
collection PubMed
description Stroke remains the number one cause of disability in the adult population. Despite scientific progress in our understanding of stroke pathology, only one treatment (tissue plasminogen activator or tPA) is able to afford benefits but to less than 3% of ischemic stroke patients. The development of experimental dietary supplement therapeutics designed to stimulate endogenous mechanisms that confer neuroprotection is likely to open new avenues for exploring stroke therapies. The present review article evaluates the recent literature supporting the benefits of dietary supplementation for the therapy of ischemic stroke. This article focuses on discussing the medical benefits of NT-020 as an adjunct agent for stroke therapy. Based on our preliminary data, a pre-stroke treatment with dietary supplementation promotes neuroprotection by decreasing inflammation and enhancing neurogenesis. However, we recognize that a pre-stroke treatment holds weak clinical relevance. Thus, the main goal of this article is to provide information about recent data that support the assumption of natural compounds as neuroprotective and to evaluate the therapeutic effects of a dietary supplement called NT-020 as in a stroke model. We focus on a systematic assessment of practical treatment parameters so that NT-020 and other dietary supplementations can be developed as an adjunct agent for the prevention or treatment of chronic diseases. We offer rationale for determining the optimal dosage, therapeutic window, and mechanism of action of NT-020 as a dietary supplement to produce neuroprotection when administered immediately after stroke onset. We highlight our long-standing principle in championing both translational and basic science approaches in an effort to fully reveal the therapeutic potential of NT-020 as dietary supplementation in the treatment of stroke. We envision dietary supplementation as an adjunct therapy for stroke at acute, subacute, and even chronic periods.
format Online
Article
Text
id pubmed-3397535
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-33975352012-07-26 Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke Kaneko, Yuji Cortes, Lourdes Sanberg, Cyndy Acosta, Sandra Bickford, Paula C. Borlongan, Cesar V. Int J Mol Sci Review Stroke remains the number one cause of disability in the adult population. Despite scientific progress in our understanding of stroke pathology, only one treatment (tissue plasminogen activator or tPA) is able to afford benefits but to less than 3% of ischemic stroke patients. The development of experimental dietary supplement therapeutics designed to stimulate endogenous mechanisms that confer neuroprotection is likely to open new avenues for exploring stroke therapies. The present review article evaluates the recent literature supporting the benefits of dietary supplementation for the therapy of ischemic stroke. This article focuses on discussing the medical benefits of NT-020 as an adjunct agent for stroke therapy. Based on our preliminary data, a pre-stroke treatment with dietary supplementation promotes neuroprotection by decreasing inflammation and enhancing neurogenesis. However, we recognize that a pre-stroke treatment holds weak clinical relevance. Thus, the main goal of this article is to provide information about recent data that support the assumption of natural compounds as neuroprotective and to evaluate the therapeutic effects of a dietary supplement called NT-020 as in a stroke model. We focus on a systematic assessment of practical treatment parameters so that NT-020 and other dietary supplementations can be developed as an adjunct agent for the prevention or treatment of chronic diseases. We offer rationale for determining the optimal dosage, therapeutic window, and mechanism of action of NT-020 as a dietary supplement to produce neuroprotection when administered immediately after stroke onset. We highlight our long-standing principle in championing both translational and basic science approaches in an effort to fully reveal the therapeutic potential of NT-020 as dietary supplementation in the treatment of stroke. We envision dietary supplementation as an adjunct therapy for stroke at acute, subacute, and even chronic periods. Molecular Diversity Preservation International (MDPI) 2012-06-15 /pmc/articles/PMC3397535/ /pubmed/22837703 http://dx.doi.org/10.3390/ijms13067424 Text en © 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Kaneko, Yuji
Cortes, Lourdes
Sanberg, Cyndy
Acosta, Sandra
Bickford, Paula C.
Borlongan, Cesar V.
Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke
title Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke
title_full Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke
title_fullStr Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke
title_full_unstemmed Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke
title_short Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke
title_sort dietary supplementations as neuroprotective therapies: focus on nt-020 diet benefits in a rat model of stroke
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397535/
https://www.ncbi.nlm.nih.gov/pubmed/22837703
http://dx.doi.org/10.3390/ijms13067424
work_keys_str_mv AT kanekoyuji dietarysupplementationsasneuroprotectivetherapiesfocusonnt020dietbenefitsinaratmodelofstroke
AT corteslourdes dietarysupplementationsasneuroprotectivetherapiesfocusonnt020dietbenefitsinaratmodelofstroke
AT sanbergcyndy dietarysupplementationsasneuroprotectivetherapiesfocusonnt020dietbenefitsinaratmodelofstroke
AT acostasandra dietarysupplementationsasneuroprotectivetherapiesfocusonnt020dietbenefitsinaratmodelofstroke
AT bickfordpaulac dietarysupplementationsasneuroprotectivetherapiesfocusonnt020dietbenefitsinaratmodelofstroke
AT borlongancesarv dietarysupplementationsasneuroprotectivetherapiesfocusonnt020dietbenefitsinaratmodelofstroke